首页 > 最新文献

Obesity最新文献

英文 中文
Human epicardial fat has a beige profile and contains higher type 2 innate lymphoid cells than subcutaneous fat 人体心外膜脂肪呈米黄色,比皮下脂肪含有更多的 2 型先天性淋巴细胞。
IF 4.2 2区 医学 Q1 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-05-15 DOI: 10.1002/oby.24023
Elisa Doukbi, Patricia Ancel, Anne Dutour, Astrid Soghomonian, Shaista Ahmed, Victoria Castejon, Christelle Piperoglou, Vlad Gariboldi, Marien Lenoir, Eric Lechevallier, Bastien Gondran-Tellier, Romain Boissier, Mikael Ebbo, Frédéric Vély, Bénédicte Gaborit

Objective

Epicardial adipose tissue (EAT) is a visceral fat that has been associated with coronary artery disease and atrial fibrillation. Previous work has revealed that EAT exhibits beige features.

Methods

First, a new pan-genomic microarray analysis was performed on previously collected paired human EAT and thoracic subcutaneous AT (thSAT) from the EPICAR study (n = 31) to decipher a specific immune signature and its link with browning genes. Then, adaptive (T and B cells) and innate lymphoid cell (ILC1, ILC2, and ILC3) immunophenotyping assay panels, including CD127, CD117, and prostaglandin D2 receptor 2, were performed on prospectively collected paired human multiorgan donors (n = 18; INTERFACE study).

Results

In the EPICAR study, a positive correlation between the T helper cell subtype Th2 immune pathway and browning genes was found in EAT versus thSAT (r = 0.82; p < 0.0001). In the INTERFACE study, this correlation was also observed (r = 0.31; p = 0.017), and a preponderance of CD4+T cells, CD8+T cells, and a few B cells was observed in all ATs (p < 0.0001). An increase in ILCs was observed in visceral AT (VAT) (i.e., EAT + VAT; 30 ± 5 ILCs per gram of AT) compared with subcutaneous counterparts (i.e., thSAT + abdominal SAT; 8 ± 2 ILCs per gram of AT; p = 0.001), with ILC1 being the most frequent (ILC1 > ILC3 > ILC2). Numbers of ILCs per gram of AT correlated with several Th2 or browning genes (IL-13, TNF receptor superfamily member 9 [TNFRSF9], and alkaline phosphatase, biomineralization associated [ALPL]). Interestingly, a specific increase in EAT-ILC2 compared with other ATs was observed, including a significant proportion expressing CD69 and/or CD25 activation markers (97.9% ± 1.2%; p < 0.0001). Finally, more natural killer cells were observed in EAT + VAT than in thSAT + abdominal SAT (p = 0.01). Exclusion of patients with coronary artery disease in the EPICAR and INTERFACE studies did not modify the main findings. Gene expression phenotyping confirmed specific upregulation of Th2 pathway and browning genes (IL-33 and uncoupling protein 1 [UCP-1]) in EAT.

Conclusions

This is the first study, to our knowledge, to provide a comparison between innate and adaptive lymphoid cells in human EAT. Further studies are ongoing to decipher whether these cells could be involved in EAT beiging.

目的:心外膜脂肪组织(EAT心外膜脂肪组织(EAT)是一种内脏脂肪,与冠心病和心房颤动有关。以往的研究表明,心外膜脂肪组织具有米色特征:方法:首先,对以前从 EPICAR 研究(n = 31)中收集的成对人体 EAT 和胸腔皮下 AT(thSAT)进行了新的泛基因组微阵列分析,以破译特定的免疫特征及其与褐变基因的联系。然后,对前瞻性收集的配对人类多器官供体(n = 18;INTERFACE 研究)进行适应性(T 细胞和 B 细胞)和先天性淋巴细胞(ILC1、ILC2 和 ILC3)免疫分型检测,包括 CD127、CD117 和前列腺素 D2 受体 2:结果:在 EPICAR 研究中发现,EAT 与 thSAT 中的 T 辅助细胞亚型 Th2 免疫途径与褐变基因之间呈正相关(r = 0.82;p +T 细胞、CD8+T 细胞和少量 B 细胞在所有 AT 中均可观察到(p ILC3 > ILC2)。每克 AT 的 ILC 数量与几个 Th2 或褐变基因(IL-13、TNF 受体超家族成员 9 [TNFRSF9] 和碱性磷酸酶、生物矿化相关 [APL])相关。有趣的是,与其他AT相比,EAT-ILC2出现了特异性增加,包括表达CD69和/或CD25活化标记的显著比例(97.9%±1.2%;P 结论:这是我们的首次研究:据我们所知,这是第一项对人类 EAT 中先天性和适应性淋巴细胞进行比较的研究。目前正在进行进一步研究,以确定这些细胞是否参与了 EAT 的形成。
{"title":"Human epicardial fat has a beige profile and contains higher type 2 innate lymphoid cells than subcutaneous fat","authors":"Elisa Doukbi,&nbsp;Patricia Ancel,&nbsp;Anne Dutour,&nbsp;Astrid Soghomonian,&nbsp;Shaista Ahmed,&nbsp;Victoria Castejon,&nbsp;Christelle Piperoglou,&nbsp;Vlad Gariboldi,&nbsp;Marien Lenoir,&nbsp;Eric Lechevallier,&nbsp;Bastien Gondran-Tellier,&nbsp;Romain Boissier,&nbsp;Mikael Ebbo,&nbsp;Frédéric Vély,&nbsp;Bénédicte Gaborit","doi":"10.1002/oby.24023","DOIUrl":"10.1002/oby.24023","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Objective</h3>\u0000 \u0000 <p>Epicardial adipose tissue (EAT) is a visceral fat that has been associated with coronary artery disease and atrial fibrillation. Previous work has revealed that EAT exhibits beige features.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>First, a new pan-genomic microarray analysis was performed on previously collected paired human EAT and thoracic subcutaneous AT (thSAT) from the EPICAR study (<i>n</i> = 31) to decipher a specific immune signature and its link with browning genes. Then, adaptive (T and B cells) and innate lymphoid cell (ILC1, ILC2, and ILC3) immunophenotyping assay panels, including CD127, CD117, and prostaglandin D2 receptor 2, were performed on prospectively collected paired human multiorgan donors (<i>n</i> = 18; INTERFACE study).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>In the EPICAR study, a positive correlation between the T helper cell subtype Th2 immune pathway and browning genes was found in EAT versus thSAT (<i>r</i> = 0.82; <i>p</i> &lt; 0.0001). In the INTERFACE study, this correlation was also observed (<i>r</i> = 0.31; <i>p</i> = 0.017), and a preponderance of CD4<sup>+</sup>T cells, CD8<sup>+</sup>T cells, and a few B cells was observed in all ATs (<i>p</i> &lt; 0.0001). An increase in ILCs was observed in visceral AT (VAT) (i.e., EAT + VAT; 30 ± 5 ILCs per gram of AT) compared with subcutaneous counterparts (i.e., thSAT + abdominal SAT; 8 ± 2 ILCs per gram of AT; <i>p</i> = 0.001), with ILC1 being the most frequent (ILC1 &gt; ILC3 &gt; ILC2). Numbers of ILCs per gram of AT correlated with several Th2 or browning genes (IL-13, TNF receptor superfamily member 9 [TNFRSF9], and alkaline phosphatase, biomineralization associated [ALPL]). Interestingly, a specific increase in EAT-ILC2 compared with other ATs was observed, including a significant proportion expressing CD69 and/or CD25 activation markers (97.9% ± 1.2%; <i>p</i> &lt; 0.0001). Finally, more natural killer cells were observed in EAT + VAT than in thSAT + abdominal SAT (<i>p</i> = 0.01). Exclusion of patients with coronary artery disease in the EPICAR and INTERFACE studies did not modify the main findings. Gene expression phenotyping confirmed specific upregulation of Th2 pathway and browning genes (IL-33 and uncoupling protein 1 [UCP-1]) in EAT.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>This is the first study, to our knowledge, to provide a comparison between innate and adaptive lymphoid cells in human EAT. Further studies are ongoing to decipher whether these cells could be involved in EAT beiging.</p>\u0000 ","PeriodicalId":215,"journal":{"name":"Obesity","volume":null,"pages":null},"PeriodicalIF":4.2,"publicationDate":"2024-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/oby.24023","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140924136","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Long-term sustained effects of the Look AHEAD lifestyle intervention on body composition among adults with type 2 diabetes Look AHEAD 生活方式干预对 2 型糖尿病成人身体成分的长期持续影响。
IF 6.9 2区 医学 Q1 Nursing Pub Date : 2024-05-13 DOI: 10.1002/oby.24025
Maxine Ashby-Thompson, Stanley Heshka, Andrea Anderson, Henry Pownall, Blandine Laferrère, Ashok Balasubramanyam, Steven B. Heymsfield, Thomas A. Wadden, Dympna Gallagher, the Look AHEAD Research Group

Objective

The objective of the study was to test whether there are sustained effects of the Look AHEAD intensive lifestyle intervention (ILI), versus diabetes support and education (DSE), on weight and body composition 12 to 16 years after randomization.

Methods

Participants were a subset of enrollees in the Look AHEAD dual-energy x-ray absorptiometry substudy who completed the final visit, composed of men (DSE = 99; ILI = 94) and women (DSE = 134; ILI = 135) with type 2 diabetes and mean (SD) age 57.2 (6.4) years and BMI 34.9 (5.1) kg/m2 at randomization. Dual-energy x-ray absorptiometry measured total and regional fat and lean masses at randomization, at Years 1, 4, and 8, and at the final visit. Linear mixed-effects regressions were applied with adjustment for group, clinic, sex, age, race/ethnicity, and baseline body composition.

Results

Weight and most body compartments were reduced by 2% to 8% (and BMI 4%) in ILI versus DSE in men but not women. ILI-induced loss of lean tissue did not show a lower percent lean mass versus DSE at 16 years after randomization.

Conclusion

ILI-related changes in weight, fat, and lean mass were detectable 12 to 16 years after randomization in men but, for unknown reasons, not in women. There was no evidence that the intervention led to a disproportionate loss of lean mass by the end of the study.

研究目的该研究的目的是测试Look AHEAD强化生活方式干预(ILI)与糖尿病支持和教育(DSE)在随机分配后12至16年是否对体重和身体成分产生持续影响:参与者是Look AHEAD双能X射线吸收测定子研究中完成最终访问的参与者子集,包括男性(DSE=99;ILI=94)和女性(DSE=134;ILI=135)2型糖尿病患者,随机化时平均(标清)年龄为57.2(6.4)岁,体重指数为34.9(5.1)kg/m2。双能 X 射线吸收测量法在随机化时、第 1、4 和 8 年以及最后一次就诊时测量总脂肪量和区域脂肪量以及瘦肉量。采用线性混合效应回归,并对组别、诊所、性别、年龄、种族/人种和基线身体成分进行调整:结果:ILI与DSE相比,男性的体重和大部分身体成分减少了2%至8%(BMI减少了4%),但女性没有减少。随机化 16 年后,ILI 引起的瘦肉组织损失与 DSE 相比并没有显示出较低的瘦肉质量百分比:结论:ILI相关的体重、脂肪和瘦体重变化在男性中可在随机化后12至16年检测到,但在女性中则无法检测到,原因不明。没有证据表明,在研究结束时,干预会导致瘦体重不成比例地减少。
{"title":"Long-term sustained effects of the Look AHEAD lifestyle intervention on body composition among adults with type 2 diabetes","authors":"Maxine Ashby-Thompson,&nbsp;Stanley Heshka,&nbsp;Andrea Anderson,&nbsp;Henry Pownall,&nbsp;Blandine Laferrère,&nbsp;Ashok Balasubramanyam,&nbsp;Steven B. Heymsfield,&nbsp;Thomas A. Wadden,&nbsp;Dympna Gallagher,&nbsp;the Look AHEAD Research Group","doi":"10.1002/oby.24025","DOIUrl":"10.1002/oby.24025","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Objective</h3>\u0000 \u0000 <p>The objective of the study was to test whether there are sustained effects of the Look AHEAD intensive lifestyle intervention (ILI), versus diabetes support and education (DSE), on weight and body composition 12 to 16 years after randomization.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>Participants were a subset of enrollees in the Look AHEAD dual-energy x-ray absorptiometry substudy who completed the final visit, composed of men (DSE = 99; ILI = 94) and women (DSE = 134; ILI = 135) with type 2 diabetes and mean (SD) age 57.2 (6.4) years and BMI 34.9 (5.1) kg/m<sup>2</sup> at randomization. Dual-energy x-ray absorptiometry measured total and regional fat and lean masses at randomization, at Years 1, 4, and 8, and at the final visit. Linear mixed-effects regressions were applied with adjustment for group, clinic, sex, age, race/ethnicity, and baseline body composition.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Weight and most body compartments were reduced by 2% to 8% (and BMI 4%) in ILI versus DSE in men but not women. ILI-induced loss of lean tissue did not show a lower percent lean mass versus DSE at 16 years after randomization.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>ILI-related changes in weight, fat, and lean mass were detectable 12 to 16 years after randomization in men but, for unknown reasons, not in women. There was no evidence that the intervention led to a disproportionate loss of lean mass by the end of the study.</p>\u0000 </section>\u0000 </div>","PeriodicalId":215,"journal":{"name":"Obesity","volume":null,"pages":null},"PeriodicalIF":6.9,"publicationDate":"2024-05-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/oby.24025","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140916602","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Metabolic surgery: The sooner the better for long-term success? 代谢手术:越早越有利于长期成功?
IF 6.9 2区 医学 Q1 Nursing Pub Date : 2024-05-07 DOI: 10.1002/oby.24054
Michael Kachmar, Vance L. Albaugh
{"title":"Metabolic surgery: The sooner the better for long-term success?","authors":"Michael Kachmar,&nbsp;Vance L. Albaugh","doi":"10.1002/oby.24054","DOIUrl":"10.1002/oby.24054","url":null,"abstract":"","PeriodicalId":215,"journal":{"name":"Obesity","volume":null,"pages":null},"PeriodicalIF":6.9,"publicationDate":"2024-05-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140878251","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Caution needed on causal inferences in obesity 肥胖症因果推论需谨慎。
IF 4.2 2区 医学 Q1 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-05-06 DOI: 10.1002/oby.24050
David S. Ludwig, Cara B. Ebbeling, Mark I. Friedman
{"title":"Caution needed on causal inferences in obesity","authors":"David S. Ludwig,&nbsp;Cara B. Ebbeling,&nbsp;Mark I. Friedman","doi":"10.1002/oby.24050","DOIUrl":"10.1002/oby.24050","url":null,"abstract":"","PeriodicalId":215,"journal":{"name":"Obesity","volume":null,"pages":null},"PeriodicalIF":4.2,"publicationDate":"2024-05-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140862147","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The association between weight loss medications and cardiovascular complications 减肥药物与心血管并发症之间的关系。
IF 4.2 2区 医学 Q1 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-05-06 DOI: 10.1002/oby.24037
Onur Baser, Gabriela Samayoa, Katarzyna Rodchenko, Lauren Isenman, Erdem Baser, Nehir Yapar

Objective

Obesity and its cardiovascular complications are major causes of morbidity and mortality. Little is known in real-world settings about the effect of newly approved antiobesity medications (AOMs) on cardiovascular complications among patients with obesity.

Methods

This retrospective cohort study examined the association between newly approved AOM use and cardiovascular events among Medicare patients with obesity using data from 2020 to 2022. Patient age, gender, comorbidity scores, socioeconomic status, and baseline cardiovascular comorbidities were compared descriptively. Subgroup analysis compared variables by medication type. Relative risk and absolute risk of cardiovascular disease (CVD) events were estimated using Cox and Aalen regression models.

Results

The analysis included 5926 patients treated with semaglutide and tirzepatide, including Ozempic (5404 patients), Wegovy (375 patients), or Mounjaro (147 patients). Hypertension, type 2 diabetes, and hyperlipidemia were the most common comorbidities. For patients with AOMs, less incidence of heart failure (4.89% vs. 6.13%, p < 0.0001), atrial fibrillation (3.83% vs. 5.17%, p < 0.0001), arrhythmia (3.59% vs. 4.14%, p < 0.0153), and peripheral vascular disease (3.44% vs. 2.94%, p < 0.0395) was found versus patients without AOMs. Patients receiving AOMs showed an 8% risk reduction in any CVD. Protective effect on CVD was apparent over the first 375 days.

Conclusions

Results suggest that utilization of AOMs effectively alleviates the high prevalence of CVD.

目的:肥胖症及其心血管并发症是发病和死亡的主要原因:肥胖症及其心血管并发症是发病和死亡的主要原因。在现实世界中,人们对新批准的抗肥胖药物(AOMs)对肥胖症患者心血管并发症的影响知之甚少:这项回顾性队列研究利用 2020 年至 2022 年的数据,研究了新批准的抗肥胖药物的使用与医保肥胖症患者心血管事件之间的关系。对患者的年龄、性别、合并症评分、社会经济状况和心血管合并症基线进行了描述性比较。分组分析比较了不同药物类型的变量。使用 Cox 和 Aalen 回归模型估算了心血管疾病(CVD)事件的相对风险和绝对风险:分析纳入了5926名接受过塞马鲁肽和替扎帕肽治疗的患者,包括Ozempic(5404名患者)、Wegovy(375名患者)或Mounjaro(147名患者)。高血压、2 型糖尿病和高脂血症是最常见的合并症。在使用 AOMs 的患者中,心力衰竭的发生率较低(4.89% 对 6.13%,p 结论:AOMs 的使用率较高:结果表明,使用 AOMs 可以有效缓解心血管疾病的高发病率。
{"title":"The association between weight loss medications and cardiovascular complications","authors":"Onur Baser,&nbsp;Gabriela Samayoa,&nbsp;Katarzyna Rodchenko,&nbsp;Lauren Isenman,&nbsp;Erdem Baser,&nbsp;Nehir Yapar","doi":"10.1002/oby.24037","DOIUrl":"10.1002/oby.24037","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Objective</h3>\u0000 \u0000 <p>Obesity and its cardiovascular complications are major causes of morbidity and mortality. Little is known in real-world settings about the effect of newly approved antiobesity medications (AOMs) on cardiovascular complications among patients with obesity.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>This retrospective cohort study examined the association between newly approved AOM use and cardiovascular events among Medicare patients with obesity using data from 2020 to 2022. Patient age, gender, comorbidity scores, socioeconomic status, and baseline cardiovascular comorbidities were compared descriptively. Subgroup analysis compared variables by medication type. Relative risk and absolute risk of cardiovascular disease (CVD) events were estimated using Cox and Aalen regression models.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>The analysis included 5926 patients treated with semaglutide and tirzepatide, including Ozempic (5404 patients), Wegovy (375 patients), or Mounjaro (147 patients). Hypertension, type 2 diabetes, and hyperlipidemia were the most common comorbidities. For patients with AOMs, less incidence of heart failure (4.89% vs. 6.13%, <i>p</i> &lt; 0.0001), atrial fibrillation (3.83% vs. 5.17%, <i>p</i> &lt; 0.0001), arrhythmia (3.59% vs. 4.14%, <i>p</i> &lt; 0.0153), and peripheral vascular disease (3.44% vs. 2.94%, <i>p</i> &lt; 0.0395) was found versus patients without AOMs. Patients receiving AOMs showed an 8% risk reduction in any CVD. Protective effect on CVD was apparent over the first 375 days.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>Results suggest that utilization of AOMs effectively alleviates the high prevalence of CVD.</p>\u0000 </section>\u0000 </div>","PeriodicalId":215,"journal":{"name":"Obesity","volume":null,"pages":null},"PeriodicalIF":4.2,"publicationDate":"2024-05-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/oby.24037","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140875132","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The carbohydrate insulin model is always correct: a point worth reiterating even when commenting on studies that do not concern it 碳水化合物胰岛素模型始终是正确的:即使在评论与之无关的研究时,这一点也值得重申。
IF 4.2 2区 医学 Q1 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-05-06 DOI: 10.1002/oby.24053
John R. Speakman, Lin Gao, Sumei Hu
{"title":"The carbohydrate insulin model is always correct: a point worth reiterating even when commenting on studies that do not concern it","authors":"John R. Speakman,&nbsp;Lin Gao,&nbsp;Sumei Hu","doi":"10.1002/oby.24053","DOIUrl":"10.1002/oby.24053","url":null,"abstract":"","PeriodicalId":215,"journal":{"name":"Obesity","volume":null,"pages":null},"PeriodicalIF":4.2,"publicationDate":"2024-05-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140856331","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Smaller subcortical volume relates to greater weight gain in girls with initially healthy weight 皮层下体积较小与最初体重健康的女孩体重增加较多有关。
IF 4.2 2区 医学 Q1 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-05-06 DOI: 10.1002/oby.24028
Shana Adise, Jonatan Ottino-Gonzalez, Panteha Hayati Rezvan, Eric Kan, Kyung E. Rhee, Michael I. Goran, Elizabeth R. Sowell

Objective

Among 3614 youth who were 9 to 12 years old and initially did not have overweight or obesity (12% [n = 385] developed overweight or obesity), we examined the natural progression of weight gain and brain structure development during a 2-year period with a high risk for obesity (e.g., pre- and early adolescence) to determine the following: 1) whether variation in maturational trajectories of the brain regions contributes to weight gain; and/or 2) whether weight gain contributes to altered brain development.

Methods

Data were gathered from the Adolescent Brain Cognitive Development (ABCD) Study. Linear mixed-effects regression models controlled for puberty, caregiver education, handedness, and intracranial volume (random effects: magnetic resonance scanner [MRI] scanner and participant). Because pubertal development occurs earlier in girls, analyses were stratified by sex.

Results

For girls, but not boys, independent of puberty, greater increases in BMI were driven by smaller volumes over time in the bilateral accumbens, amygdala, hippocampus, and thalamus, right caudate and ventral diencephalon, and left pallidum (all p < 0.05).

Conclusions

The results suggest a potential phenotype for identifying obesity risk because underlying differences among regions involved in food intake were related to greater weight gain in girls, but not in boys. Importantly, 2 years of weight gain may not be sufficient to alter brain development, highlighting early puberty as a critical time to prevent negative neurological outcomes.

研究目的在 3614 名 9 至 12 岁、最初没有超重或肥胖(12% [n = 385] 出现超重或肥胖)的青少年中,我们研究了肥胖高风险期(如青春期前期和早期)2 年内体重增加和大脑结构发育的自然进程,以确定以下几点:1)大脑区域成熟轨迹的变化是否导致体重增加;和/或 2)体重增加是否导致大脑发育改变:方法:数据来自青少年大脑认知发展(ABCD)研究。线性混合效应回归模型控制了青春期、照顾者教育程度、手性和颅内容积(随机效应:磁共振扫描仪[MRI]扫描仪和参与者)。由于女孩的青春期发育较早,因此按性别进行了分层分析:结果表明:对于女孩(而非男孩)而言,与青春期无关,随着时间的推移,双侧累加器、杏仁核、海马和丘脑、右侧尾状脑和腹侧间脑以及左侧苍白球的体积变小,会导致体重指数的增加(均为 p 结论:对于男孩而言,随着时间的推移,双侧累加器、杏仁核、海马和丘脑、右侧尾状脑和腹侧间脑以及左侧苍白球的体积变小,会导致体重指数的增加:研究结果表明,参与食物摄入的区域之间的潜在差异与女孩体重增加有关,而与男孩体重增加无关,因此有可能通过表型来识别肥胖风险。重要的是,2 年的体重增加可能不足以改变大脑的发育,因此青春期早期是预防神经系统不良后果的关键时期。
{"title":"Smaller subcortical volume relates to greater weight gain in girls with initially healthy weight","authors":"Shana Adise,&nbsp;Jonatan Ottino-Gonzalez,&nbsp;Panteha Hayati Rezvan,&nbsp;Eric Kan,&nbsp;Kyung E. Rhee,&nbsp;Michael I. Goran,&nbsp;Elizabeth R. Sowell","doi":"10.1002/oby.24028","DOIUrl":"10.1002/oby.24028","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Objective</h3>\u0000 \u0000 <p>Among 3614 youth who were 9 to 12 years old and initially did not have overweight or obesity (12% [<i>n</i> = 385] developed overweight or obesity), we examined the natural progression of weight gain and brain structure development during a 2-year period with a high risk for obesity (e.g., pre- and early adolescence) to determine the following: 1) whether variation in maturational trajectories of the brain regions contributes to weight gain; and/or 2) whether weight gain contributes to altered brain development.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>Data were gathered from the Adolescent Brain Cognitive Development (ABCD) Study. Linear mixed-effects regression models controlled for puberty, caregiver education, handedness, and intracranial volume (random effects: magnetic resonance scanner [MRI] scanner and participant). Because pubertal development occurs earlier in girls, analyses were stratified by sex.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>For girls, but not boys, independent of puberty, greater increases in BMI were driven by smaller volumes over time in the bilateral accumbens, amygdala, hippocampus, and thalamus, right caudate and ventral diencephalon, and left pallidum (all <i>p</i> &lt; 0.05).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>The results suggest a potential phenotype for identifying obesity risk because underlying differences among regions involved in food intake were related to greater weight gain in girls, but not in boys. Importantly, 2 years of weight gain may not be sufficient to alter brain development, highlighting early puberty as a critical time to prevent negative neurological outcomes.</p>\u0000 </section>\u0000 </div>","PeriodicalId":215,"journal":{"name":"Obesity","volume":null,"pages":null},"PeriodicalIF":4.2,"publicationDate":"2024-05-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11211063/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140873032","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The grade of obesity affects the noninvasive diagnosis of advanced fibrosis in individuals with MASLD 肥胖程度影响 MASLD 患者晚期纤维化的无创诊断
IF 6.9 2区 医学 Q1 Nursing Pub Date : 2024-05-03 DOI: 10.1002/oby.24033
Yasmina Chouik, Adrien Aubin, Marianne Maynard-Muet, Bérénice Segrestin, Laurent Milot, Valérie Hervieu, Fabien Zoulim, Emmanuel Disse, Massimo Levrero, Cyrielle Caussy

Objective

Metabolic dysfunction-associated steatotic liver disease (MASLD) is closely associated with obesity. We aimed to assess the impact of obesity on the performance of different noninvasive tests, including liver stiffness measurement (LSM) and Agile3+ (A3+), to detect advanced fibrosis (AF) in a population of patients with MASLD encompassing a wide range of BMI values.

Methods

A total of 479 patients with MASLD were consecutively included (Lyon Hepatology Institute). Clinical data and noninvasive tests, including FibroTest, LSM, A3+, Fibrosis-4 (FIB-4), magnetic resonance elastography, and liver biopsies, were collected. AF was determined by a composite endpoint, i.e., histological stage ≥ F3, overt diagnosis of cirrhosis by magnetic resonance elastography, or concordant LSM ≥ 9.6 kPa and FibroTest ≥ F3.

Results

The median BMI was 35.0 kg/m2, and the prevalence of AF was 28.6%. Patients with BMI ≥ 35 versus <35 had a lower proportion of AF, i.e., 19.3% versus 38.1% (p < 0.001), but higher indeterminate status for AF (34.2% vs. 15.4%; p < 0.001). In the case of BMI ≥ 35, LSM had lower specificity to rule in AF (77.9%) versus A3+ (90.4%), but A3+ had decreased sensitivity to rule out AF. A sequential LSM/A3+ strategy achieved high specificity to rule in AF and lowered the proportion of indeterminate cases in patients with BMI ≥ 35.

Conclusions

The grade of obesity affects the detection of MASLD-related AF. A sequential use of LSM/A3+ could improve AF detection in patients with BMI ≥ 35.

目标代谢功能障碍相关性脂肪性肝病(MASLD)与肥胖密切相关。我们旨在评估肥胖对不同无创检验(包括肝脏硬度测量(LSM)和 Agile3+ (A3+))性能的影响,这些无创检验可在 BMI 值范围广泛的 MASLD 患者群体中检测晚期纤维化(AF)。收集了临床数据和非侵入性检查,包括纤维测试、LSM、A3+、纤维化-4(FIB-4)、磁共振弹性成像和肝活检。房颤由综合终点决定,即组织学分期≥ F3、磁共振弹性成像明显诊断为肝硬化或 LSM ≥ 9.6 kPa 和 FibroTest ≥ F3 一致。体重指数≥35的患者与体重指数<35的患者相比,房颤比例较低,分别为19.3%和38.1%(P< 0.001),但房颤不确定状态的比例较高(34.2%和15.4%;P< 0.001)。在体重指数≥35的情况下,LSM排除房颤的特异性(77.9%)低于A3+(90.4%),但A3+排除房颤的敏感性降低。在 BMI ≥ 35 的患者中,LSM/A3+ 顺序策略可实现较高的房颤排除特异性,并降低不确定病例的比例。连续使用 LSM/A3+ 可以提高 BMI≥35 患者的房颤检出率。
{"title":"The grade of obesity affects the noninvasive diagnosis of advanced fibrosis in individuals with MASLD","authors":"Yasmina Chouik,&nbsp;Adrien Aubin,&nbsp;Marianne Maynard-Muet,&nbsp;Bérénice Segrestin,&nbsp;Laurent Milot,&nbsp;Valérie Hervieu,&nbsp;Fabien Zoulim,&nbsp;Emmanuel Disse,&nbsp;Massimo Levrero,&nbsp;Cyrielle Caussy","doi":"10.1002/oby.24033","DOIUrl":"10.1002/oby.24033","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Objective</h3>\u0000 \u0000 <p>Metabolic dysfunction-associated steatotic liver disease (MASLD) is closely associated with obesity. We aimed to assess the impact of obesity on the performance of different noninvasive tests, including liver stiffness measurement (LSM) and Agile3+ (A3+), to detect advanced fibrosis (AF) in a population of patients with MASLD encompassing a wide range of BMI values.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>A total of 479 patients with MASLD were consecutively included (Lyon Hepatology Institute). Clinical data and noninvasive tests, including FibroTest, LSM, A3+, Fibrosis-4 (FIB-4), magnetic resonance elastography, and liver biopsies, were collected. AF was determined by a composite endpoint, i.e., histological stage ≥ F3, overt diagnosis of cirrhosis by magnetic resonance elastography, or concordant LSM ≥ 9.6 kPa and FibroTest ≥ F3.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>The median BMI was 35.0 kg/m<sup>2</sup>, and the prevalence of AF was 28.6%. Patients with BMI ≥ 35 versus &lt;35 had a lower proportion of AF, i.e., 19.3% versus 38.1% (<i>p</i> &lt; 0.001), but higher indeterminate status for AF (34.2% vs. 15.4%; <i>p</i> &lt; 0.001). In the case of BMI ≥ 35, LSM had lower specificity to rule in AF (77.9%) versus A3+ (90.4%), but A3+ had decreased sensitivity to rule out AF. A sequential LSM/A3+ strategy achieved high specificity to rule in AF and lowered the proportion of indeterminate cases in patients with BMI ≥ 35.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>The grade of obesity affects the detection of MASLD-related AF. A sequential use of LSM/A3<sup>+</sup> could improve AF detection in patients with BMI ≥ 35.</p>\u0000 </section>\u0000 </div>","PeriodicalId":215,"journal":{"name":"Obesity","volume":null,"pages":null},"PeriodicalIF":6.9,"publicationDate":"2024-05-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/oby.24033","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140842199","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Adaptive thermogenesis, at the level of resting energy expenditure, after diet alone or diet plus bariatric surgery 单纯节食或节食加减肥手术后静息能量消耗水平的适应性产热。
IF 6.9 2区 医学 Q1 Nursing Pub Date : 2024-04-25 DOI: 10.1002/oby.24031
Silvia Y. Lopez Torres, Marthe I. Aukan, Barbara A. Gower, Catia Martins

Objective

The objective of this study was to compare the magnitude of adaptive thermogenesis (AT), at the level of resting energy expenditure (REE), after a very low-energy diet alone or combined with Roux-en-Y gastric bypass or sleeve gastrectomy, as well as to investigate the association between AT and changes in appetite.

Methods

A total of 44 participants with severe obesity underwent 10 weeks of a very low-energy diet alone or combined with Roux-en-Y gastric bypass or sleeve gastrectomy. Body weight and composition, REE, subjective appetite feelings, and plasma concentrations of gastrointestinal hormones were measured at baseline and week 11. AT, at the level of REE, was defined as a significantly lower measured versus predicted (using a regression model with baseline data) REE.

Results

Participants lost 18.4 ± 3.9 kg of body weight and experienced AT, at the level of REE (−121 ± 188 kcal/day; p < 0.001), with no differences among groups. The larger the AT, at the level of REE, the greater the reduction in fasting ghrelin concentrations and the smaller the reduction in feelings of hunger and desire to eat in the postprandial state.

Conclusions

Weight-loss modality does not seem to modulate the magnitude of AT, at the level of REE. The greater the AT, at the level of REE, the greater the drive to eat following weight loss.

方法共有 44 名重度肥胖症患者接受了为期 10 周的极低能量饮食或 Roux-en-Y 胃旁路术或袖带胃切除术。在基线和第 11 周测量了体重和成分、REE、主观食欲感觉以及血浆中胃肠激素的浓度。结果参与者体重减轻了 18.4 ± 3.9 千克,REE 水平出现 AT(-121 ± 188 千卡/天;p < 0.001),组间无差异。在 REE 水平上,AT 越大,空腹胃泌素浓度的降低幅度越大,餐后饥饿感和进食欲望的降低幅度越小。在 REE 水平上,AT 越大,减肥后进食的动力就越大。
{"title":"Adaptive thermogenesis, at the level of resting energy expenditure, after diet alone or diet plus bariatric surgery","authors":"Silvia Y. Lopez Torres,&nbsp;Marthe I. Aukan,&nbsp;Barbara A. Gower,&nbsp;Catia Martins","doi":"10.1002/oby.24031","DOIUrl":"10.1002/oby.24031","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Objective</h3>\u0000 \u0000 <p>The objective of this study was to compare the magnitude of adaptive thermogenesis (AT), at the level of resting energy expenditure (REE), after a very low-energy diet alone or combined with Roux-en-Y gastric bypass or sleeve gastrectomy, as well as to investigate the association between AT and changes in appetite.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>A total of 44 participants with severe obesity underwent 10 weeks of a very low-energy diet alone or combined with Roux-en-Y gastric bypass or sleeve gastrectomy. Body weight and composition, REE, subjective appetite feelings, and plasma concentrations of gastrointestinal hormones were measured at baseline and week 11. AT, at the level of REE, was defined as a significantly lower measured versus predicted (using a regression model with baseline data) REE.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Participants lost 18.4 ± 3.9 kg of body weight and experienced AT, at the level of REE (−121 ± 188 kcal/day; <i>p</i> &lt; 0.001), with no differences among groups. The larger the AT, at the level of REE, the greater the reduction in fasting ghrelin concentrations and the smaller the reduction in feelings of hunger and desire to eat in the postprandial state.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>Weight-loss modality does not seem to modulate the magnitude of AT, at the level of REE. The greater the AT, at the level of REE, the greater the drive to eat following weight loss.</p>\u0000 </section>\u0000 </div>","PeriodicalId":215,"journal":{"name":"Obesity","volume":null,"pages":null},"PeriodicalIF":6.9,"publicationDate":"2024-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/oby.24031","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140658064","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Presurgery health influences outcomes following vertical sleeve gastrectomy in adolescents 手术前健康状况对青少年垂直袖状胃切除术后效果的影响。
IF 6.9 2区 医学 Q1 Nursing Pub Date : 2024-04-25 DOI: 10.1002/oby.24018
Debi Swertfeger, Ahlee Kim, Hannah Sexmith, Maria E. Moreno-Fernandez, W. Sean Davidson, Michael Helmrath, Todd Jenkins, Tsuyoshi Okura, Esmond Geh, Stavra A. Xanthakos, Sara Szabo, Takahisa Nakamura, Senad Divanovic, Amy Sanghavi Shah

Objective

Weight loss following vertical sleeve gastrectomy (VSG) in youth can range from 10% to 50%. We examined whether there are differences in demographic or metabolic parameters before VSG in youth who achieve above-average weight loss (AAWL) versus below-average weight loss (BAWL) at 1 year post VSG and if youth with BAWL still achieve metabolic health improvements at 1 year post VSG.

Methods

Demographic, anthropometric, and clinical lab data were collected before VSG and at 1, 3, 6, and 12 months after VSG.

Results

Forty-three youth with a mean age of 16.9 (SD 1.7) years before VSG were studied; 70% were female, 19% non-Hispanic Black, 58% non-Hispanic White, and 23% mixed/other race. Mean baseline BMI was 51.1 (SD 10.5) kg/m2. Average weight loss was 25.8%. The AAWL group lost 18.6 kg/m2 (35.3%) versus the BAWL group, who lost 8.8 kg/m2 (17.5%). BMI, age, race, sex, and socioeconomic status at baseline were similar between AAWL and BAWL groups; however, the BAWL group had a higher frequency of pre-VSG dysglycemia, steatotic liver disease, and dyslipidemia. At 1 year post VSG, fewer youth in the BAWL group achieved ideal health parameters, and they had less resolution of comorbidities.

Conclusions

The presence of comorbidities before VSG is associated with less weight loss and reduced resolution of metabolic conditions at 1 year post VSG.

目的:青少年在接受垂直袖带胃切除术(VSG)后,体重可下降 10% 至 50%。我们研究了在 VSG 术后 1 年,体重减轻超过平均水平 (AAWL) 的青少年与体重减轻低于平均水平 (BAWL) 的青少年在 VSG 术前的人口统计学或代谢参数是否存在差异,以及体重减轻低于平均水平的青少年在 VSG 术后 1 年是否仍能改善代谢健康。结果接受研究的 43 名青少年在 VSG 之前的平均年龄为 16.9 岁(标准差为 1.7 岁),其中 70% 为女性,19% 为非西班牙裔黑人,58% 为非西班牙裔白人,23% 为混血/其他种族。平均基线体重指数为 51.1 (SD 10.5) kg/m2。平均体重减轻 25.8%。AAWL 组减重 18.6 kg/m2(35.3%),而 BAWL 组减重 8.8 kg/m2(17.5%)。AAWL组和BAWL组基线时的体重指数、年龄、种族、性别和社会经济状况相似;但BAWL组在VSG前出现血糖异常、脂肪肝和血脂异常的频率更高。VSG 后 1 年时,BAWL 组中达到理想健康参数的青少年人数较少,他们的合并症缓解程度也较低。
{"title":"Presurgery health influences outcomes following vertical sleeve gastrectomy in adolescents","authors":"Debi Swertfeger,&nbsp;Ahlee Kim,&nbsp;Hannah Sexmith,&nbsp;Maria E. Moreno-Fernandez,&nbsp;W. Sean Davidson,&nbsp;Michael Helmrath,&nbsp;Todd Jenkins,&nbsp;Tsuyoshi Okura,&nbsp;Esmond Geh,&nbsp;Stavra A. Xanthakos,&nbsp;Sara Szabo,&nbsp;Takahisa Nakamura,&nbsp;Senad Divanovic,&nbsp;Amy Sanghavi Shah","doi":"10.1002/oby.24018","DOIUrl":"10.1002/oby.24018","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Objective</h3>\u0000 \u0000 <p>Weight loss following vertical sleeve gastrectomy (VSG) in youth can range from 10% to 50%. We examined whether there are differences in demographic or metabolic parameters before VSG in youth who achieve above-average weight loss (AAWL) versus below-average weight loss (BAWL) at 1 year post VSG and if youth with BAWL still achieve metabolic health improvements at 1 year post VSG.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>Demographic, anthropometric, and clinical lab data were collected before VSG and at 1, 3, 6, and 12 months after VSG.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Forty-three youth with a mean age of 16.9 (SD 1.7) years before VSG were studied; 70% were female, 19% non-Hispanic Black, 58% non-Hispanic White, and 23% mixed/other race. Mean baseline BMI was 51.1 (SD 10.5) kg/m<sup>2</sup>. Average weight loss was 25.8%. The AAWL group lost 18.6 kg/m<sup>2</sup> (35.3%) versus the BAWL group, who lost 8.8 kg/m<sup>2</sup> (17.5%). BMI, age, race, sex, and socioeconomic status at baseline were similar between AAWL and BAWL groups; however, the BAWL group had a higher frequency of pre-VSG dysglycemia, steatotic liver disease, and dyslipidemia. At 1 year post VSG, fewer youth in the BAWL group achieved ideal health parameters, and they had less resolution of comorbidities.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>The presence of comorbidities before VSG is associated with less weight loss and reduced resolution of metabolic conditions at 1 year post VSG.</p>\u0000 </section>\u0000 </div>","PeriodicalId":215,"journal":{"name":"Obesity","volume":null,"pages":null},"PeriodicalIF":6.9,"publicationDate":"2024-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/oby.24018","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140658598","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Obesity
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1